White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration
- 285 Downloads
The objective of the current study was to quantify the degree of white matter (WM) abnormalities in chronic and virally suppressed HIV-infected (HIV+) persons while carefully taking into account demographic and disease factors. Diffusion tensor imaging (DTI) was conducted in 40 HIV− and 82 HIV+ men with comparable demographics and life style factors. The HIV+ sample was clinically stable with successful viral control. Diffusion was measured across 32 non-colinear directions with a b-value of 1000 s/mm2; fractional anisotropy (FA) and mean diffusivity (MD) maps were quantified with Itrack IDL. Using the ENIGMA DTI protocol, FA and MD values were extracted for each participant and in 11 skeleton regions of interest (SROI) from standard labels in the JHU ICBM-81 atlas covering major striato-frontal and parietal tracks. We found no major differences in FA and MD values across the 11 SROI between study groups. Within the HIV+ sample, we found that a higher CNS penetrating antiretroviral treatment, higher current CD4+ T cell count, and immune recovery from the nadir CD4+ T cell count were associated with increased FA and decreased MD (p < 0.05–0.006), while HIV duration, symptomatic, and asymptomatic cognitive impairment were associated with decreased FA and increased MD (p < 0.01–0.004). Stability of HIV treatment and antiretroviral CNS penetration efficiency in addition to current and historical immune recovery were related to higher FA and lower MD (p = 0.04–p < 0.01). In conclusion, WM DTI measures are near normal except for patients with neurocognitive impairment and longer HIV disease duration.
KeywordsHIV/AIDS HIV-associated neurocognitive disorder Diffusion tensor imaging Antiretroviral treatment Immune functions
We would like to thank the participants for their time.
(1) Conception and design of the study: LAC, BJB, CR, RGH.
(2) Acquisition and analysis of data: JS, JG, MS, KM.
(3) Drafting a significant portion of the manuscript or figures: LAC, BJB, CR, JS, MG, RGH.
Compliance with ethical standards
NHMRC project grant (APP568746; CIA/PI Cysique) and NHMRC Career Development Fellowship (APP1045400; CIA/PI Cysique), Peter Duncan Neuroscience Unit at the Sydney St. Vincent’s Hospital Applied Medical Research Centre (Director: Prof. Brew).
Conflict of interest
All authors report no disclosure for the submitted work.
Dr. Cysique reports a Gilead science fellowship grant, outside the submitted work.
Prof. Brew reports personal fees from AbbVie, personal fees from Viiv, grants and personal fees from Biogen Idec, personal fees from Merck Sharpe and Dohme, grants from National Health and Medical Research Council, and grants from National Institutes of Health, outside the submitted work.
Prof. Rae reports personal fees from Philips Healthcare and personal fees from Springer, outside the submitted work.
Other authors report no disclosures outside the submitted work.
- Correa DG, Zimmermann N, Tukamoto G, Doring T, Ventura N, Leite SC, Cabral RF, Fonseca RP, Bahia PR, Gasparetto EL (2016) Longitudinal assessment of subcortical gray matter volume, cortical thickness, and white matter integrity in HIV-positive patients. J Magn Reson Imaging 25263Google Scholar
- Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neuro-Oncol 17:176–183Google Scholar
- Cysique LA, Heaton RK, Kamminga J, Lane T, Gates TM, Moore DM, Hubner E, Carr A, Brew BJ (2014) HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neuro-Oncol 20:258–268Google Scholar
- ENIGMA DTI protocol (2015) [Online]. Available: http://enigma.ini.usc.edu/protocols/dti-protocols/ (Accessed Oct 15th 2015)
- Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I, The CG (2009) White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol 15:187–195CrossRefPubMedPubMedCentralGoogle Scholar
- Gongvatana A, Cohen RA, Correia S, Devlin KN, Miles J, Kang H, Ombao H, Navia B, Laidlaw DH, Tashima KT (2011) Clinical contributors to cerebral white matter integrity in HIV-infected individuals. J Neuro-Oncol 17:477–486Google Scholar
- Pelle MT, Bazille C, Gray F (2008). Neuropathology and HIV Dementia. In: Handbook of Clinical Neurology. Elsevier, pp. 807–818Google Scholar
- Sailasuta N, Ross W, Ananworanich J, Chalermchai T, DeGruttola V, Lerdlum S, Pothisri M, Busovaca E, Ratto-Kim S, Jagodzinski L, Spudich S, Michael N, Kim JH, Valcour V (2012) Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One 7:e49272CrossRefPubMedPubMedCentralGoogle Scholar
- Seider TR, Gongvatana A, Woods AJ, Chen H, Porges EC, Cummings T, Correia S, Tashima K, Cohen RA (2015) Age exacerbates HIV-associated white matter abnormalities. J Neuro-Oncol 7:7Google Scholar
- Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(Suppl 1):S208–S219CrossRefPubMedGoogle Scholar
- The Kirby Institute (2015). HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2015. The Kirby Institute, Sydney 2052Google Scholar
- Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Kumar A, Soni S, Sibtain NA, Reed L, Bradbeer C, Barker GJ, Kopelman MD (2012) Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 48:230–241CrossRefPubMedGoogle Scholar
- Winston A, Puls R, Kerr SJ, Duncombe C, Li P, Gill JM, Ramautarsing R, Taylor-Robinson SD, Emery S, Cooper DA (2015) Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART. PLoS One 10:e0118608CrossRefPubMedPubMedCentralGoogle Scholar
- Zhu T, Zhong J, Hu R, Tivarus M, Ekholm S, Harezlak J, Ombao H, Navia B, Cohen R, Schifitto G (2013) Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study. J Neuro-Oncol 19:10–23Google Scholar